1 / 6

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause of small cell lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. It can be further classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer is caused by smoking tobacco, or second hand smoking, or on exposure to asbestos, chromium, arsenic, nickel, soot, or radon. The common symptoms associated with lung cancer are chest pain, incurable cough, blood in sputum, fatigue, loss of appetite, unintentional weight loss, shortness of breath, and wheezing. Small cell lung cancer has a poor prognosis and gets diagnosed only at the late stage of disease progression, and hence, has a high mortality rate. There are no therapies available to cure small cell lung cancer in the market. Analysts forecast the Global Small Cell Lung Cancer Therapeutics market to grow at a CAGR of 3.60 percent over the period 2014-2019. Read more details at @ http://www.bigmarketresearch.com/global-small-cell-lung-cancer-therapeutics-2015-2019-market

jeffrieskerry6
Download Presentation

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Top 10 Diabetes Care Technologies, Devices and Therapeutics Markets - Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast 2012 - 2020 Global Small Cell Lung Cancer Therapeutics Market 2015-2019

  2. Description Report Overview About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause of small cell lung cancer, though it also occurs in non-smokers. Small cell lung cancer is caused by smoking tobacco, or second hand smoking, or on exposure to asbestos, chromium, arsenic, nickel, soot, or radon. The common symptoms associated with lung cancer are chest pain, incurable cough, blood in sputum, fatigue, loss of appetite, unintentional weight loss, shortness of breath, and wheezing. Small cell lung cancer has a poor prognosis and gets diagnosed only at the late stage of disease progression, and hence, has a high mortality rate. There are no therapies available to cure small cell lung cancer in the market. Analysts forecast the Global Small Cell Lung Cancer Therapeutics market to grow at a CAGR of 3.60 percent over the period 2014-2019. Read more details at @ http://www.bigmarketresearch.com/global-small-cell-lung-cancer-therapeutics-2015-2019-market @Bigmarketresearch

  3. Description Report Overview Covered in this Report Global Small Cell Lung Cancer Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Small Cell Lung Cancer Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas • APAC • EMEA Key Vendors • Bristol-Myers Squibb • GlaxoSmithKline • Menarini • Sanofi @Bigmarketresearch

  4. Description Report Overview Market Driver • High Unmet Need • For a full, detailed list, view our report Market Challenge • High Cost of Treatment • For a full, detailed list, view our report Market Trend • Strategic Alliances • For a full, detailed list, view our report Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/183626 @Bigmarketresearch

  5. Table Of Contents Table Of Content • 01. Executive Summary • 02. List of Abbreviations • 03. Scope of the Report • 04. Market Research Methodology • 05. Disease Overview • 06. Introduction • 07. Market Landscape • 08 Pipeline Analysis • 09. Market Segmentation by Therapeutic Class of Drugs • 10 Market Segmentation by Route of Administration • 11 Market Segmentation by Dosage Form • 12 Geographical Segmentation • 13 Buying Criteria • 14 Market Growth Drivers • 15 Drivers and their Impact • 16 Market Challenges • 17 Impact of Drivers and Challenges • 18 Market Trends • 19 Trends and their Impact • 20 Vendor Landscape • 21 Key Vendor Analysis • 22 Other Reports in this Series @Bigmarketresearch

  6. Get Full Information At: http://www.bigmarketresearch.com/global-small-cell-lung-cancer-therapeutics-2015-2019-market

More Related